Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02449213 · ClinicalTrials.gov registry record
A Biobehavioral Model of Diabetes Risk in Chinese Immigrants
A clinical trial, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- 650
- Enrollment target
NCT02449213 is a clinical trial that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 650 participants.
The verdict
NCT02449213 has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- 650 participants
- Enrollment target
Study Summary
This prospective, longitudinal study of Chinese American immigrants will examine whether psychosocial factors (e.g., acculturative stress, social isolation, discrimination) are associated with markers of type 2 diabetes risk over time, and whether such associations are mediated by inflammatory pathways.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2016-03-11 |
| Est. Completion | 2021-05-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02449213
The ClinicalTrials.gov registry entry for NCT02449213 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02449213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02449213 about?
NCT02449213 is a clinical study titled "A Biobehavioral Model of Diabetes Risk in Chinese Immigrants". This prospective, longitudinal study of Chinese American immigrants will examine whether psychosocial factors (e.g., acculturative stress, social isolation, discrimination) are associated with markers of type 2 diabetes risk over time, and whether such associations are mediated by inflammatory pathw...
What is the current status of trial NCT02449213?
This trial is currently completed. The enrollment target is 650 participants. The study started on 2016-03-11. Estimated completion is 2021-05-05.
Who is sponsoring clinical trial NCT02449213?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.